jobs

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BIOVF

Recent news which mentions BIOVF

Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
Tickers BIOVF MRK NEWS
Tags Benzinga Top Stories Market News
From Benzinga
Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases
Tickers APLS BIOVF NEWS SWOBY
Tags SWOBY Briefs BIOVF
From Benzinga
Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
Tickers AZN BIOVF PFE SNY
Tags SNY Briefs BIOVF
From Benzinga
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
Tickers AZN AZNCF BIOVF SNY
Tags FDA Large Cap Biotech
From Benzinga
Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study
Tickers APLS BIOVF
Tags Equities Health Care General
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Tickers ABNB BIOVF CTIC PACW
Tags BIOVF banks Stock Whisper Index
From Benzinga
Why Shares of CTI BioPharma Are Soaring Wednesday
Tickers BIOVF CTIC
Tags Market News CTIC Recent Press Releases
From Motley Fool
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
Tickers BIOVF CTIC
Tags Trading Ideas Biotech Market News
From Benzinga
Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
Tickers BIOVF SELB
Tags Penny Stocks BIOVF Briefs
From Benzinga
Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
Tickers BIOVF VERU
Tags Benzinga Sabizabulin Market News
From Benzinga
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
Tickers AZN AZNCF BIOVF SNY
Tags European Medicines Agency Eurasia Market News
From Benzinga
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
Tickers BIOVF SNY
Tags Biotech Large Cap News
From Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
Tickers BIOVF CANF IBB INVA
Tags SNY Penny Stocks BIOVF
From Benzinga
SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis
Tickers BIOVF SNY
Tags News Biotech General
From Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Tickers ADCT ANNX ATHX BIOVF
Tags Management ANNX Health Care
From Benzinga
ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug
Tickers ADCT BIOVF
Tags Small Cap BIOVF Briefs
From Benzinga
Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
Tickers BIOVF SNY
Tags Health Care Phase 3 Results General
From Benzinga
Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
Tickers APLS BIOVF
Tags Briefs Blood Disorders BIOVF
From Benzinga
AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report
Tickers AZN AZNCF BIOVF
Tags Biotech Benzinga Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News Instagram Instagram
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

922 Allowance Ave SE
Medicine Hat, AB T1A 3G7

Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.

[P] 403.527.1101
[F] 403-527-0737

Print Advertising: 403.528.5659
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2024 The Medicine Hat News